Respiratory syncytial virus (RSV) is increasingly recognized as a major pathogen in frail older adults and a cause of exacerbations of chronic obstructive pulmonary disease (COPD). Although there are studies examining the burden in hospitalized COPD cohorts, there has been no work evaluating the burden in the outpatient setting in this group.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- IBDmatters - Advanced Therapeutic Treatments
Examinations and considerations before therapy
- Journal Club
Management of axial spondyloarthritis
- Multiple myeloma
DREAMM-7: Belamaf plus bortezomib and dexamethasone outperforms comparator therapy
- COPD
Better outcomes through patient education and integrated care
- Interview
“Wearables are increasingly accepted as an aid”
- Exogenous allergic alveolitis
Recommendations for therapy for the first time
- Kidney cancer
Urine test could halve the number of postoperative kidney cancer scans
- Evidence, potential and limits